Construction of a 10-year Pharmacogenetic Literature Database with Information on Alternative Allele Frequency: PharmGAF DB
Research in Clinical Pharmacy · 2023
DOI: 10.59931/rcp.23.0003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Clinical Pharmacy, 2023. Verfasst von Hyun Kyung Lee und 5 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BYNC 4.0). Gefördert von: Ministry of Food and Drug Safety.
Abstract (Originalsprache)
Background
Following the rapid growth in genetic information related to drug responses, the urgent need to organize this information for clinical use has arisen.The current databases used in Korea lack information about drug responses as they pertain to specific ethnic groups, including Koreans, and the frequency of genomic variants.This study aimed to develop a pharmacogenetics-alternative allele frequency (AAF) database (PharmGAF DB) in South Korea to address this issue.
Methods
Drugs were selected from the drug response database of the Korean Ministry of Food and Drug Safety by studying various pharmacogenetic guidelines such as Clinical Pharmacogenetics Implementation Consortium, Dutch Pharmacogenetics Working Group, and Canadian Pharmacogenomics Network for Drug Safety and drug labels accepted by various health authorities such as the United States Food and Drug Administration, European Medicines Agency, and the Pharmaceuticals and Medical Devices Agency.Information on drug responses was collected and updated for a set of selected drugs from pharmacogenetics literature over the past ten years.AAF information was gathered from the Korean Reference Genome Database, the single nucleotide polymorphism database, and the Allele Frequency Net Database.
Results
In total, 80 drugs were investigated, and the pharmacogenomic effects of 142 variants in relation to these drugs were updated.Pharmacokinetic effects were found for 51 variants and pharmacodynamic effects were found for 111 variants.AAF information was collected for these variants in Korean, East Asian, and Caucasian populations.Variants for which AAF significantly differed between Koreans and Caucasians were identified.Finally, PharmGAF DB was created by combining information on the pharmacogenomic effects and the AAF. Conclusion:The newly developed database, PharmGAF DB, was created by merging information on how drug responses relate to genotypes and allele frequencies among different ethnic groups.PharmGAF DB should improve drug efficacy and reduce the occurrence of side effects by supporting the implementation of precision medicine in clinical practice.
Förderung
- Ministry of Food and Drug Safety
Zitieren
APA
Lee, H. K., Jang, H. Y., Lee, Y. H., Han, N., Kim, I., & Oh, J. M. (2023). Construction of a 10-year Pharmacogenetic Literature Database with Information on Alternative Allele Frequency: PharmGAF DB. Research in Clinical Pharmacy. https://doi.org/10.59931/rcp.23.0003
Vancouver
Lee HK, Jang HY, Lee YH, Han N, Kim I, Oh JM. Construction of a 10-year Pharmacogenetic Literature Database with Information on Alternative Allele Frequency: PharmGAF DB. Research in Clinical Pharmacy. 2023. doi:10.59931/rcp.23.0003
BibTeX
@article{Lee2023,
author = {Lee, Hyun Kyung and Jang, Ha Young and Lee, Yu Hyun and Han, Nayoung and Kim, In-Wha and Oh, Jung Mi},
title = {Construction of a 10-year Pharmacogenetic Literature Database with Information on Alternative Allele Frequency: PharmGAF DB},
journal = {Research in Clinical Pharmacy},
year = {2023},
doi = {10.59931/rcp.23.0003}
}
EUVIMED